IOC

Family Herpesviridae and neuroinfections: current status and research in progress

Genomic surveillance: a potential shortcut for effective Chagas disease management

Mapping Yellow fever epidemics as a potential indicator of the historical range of Aedes aegypti in the United States

Accuracy of rapid point-of-care serological tests for leprosy diagnosis: a systematic review and meta-analysis

Perspectives for a new drug candidate for Chagas disease therapy

Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress

Translational research in Chagas disease: perspectives in nutritional therapy emerging from selenium supplementation studies as a complementary treatment

Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach*

Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors

Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target

Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease

Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy

Past and future of trypanosomatids high-throughput phenotypic screening

Computational approaches towards the discovery and optimisation of cruzain inhibitors

Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors

How people affected by Chagas disease have struggled with their negligence: history, associative movement and World Chagas Disease Day

Animal models and SARS-CoV-2-induced pulmonary and neurological injuries

Is the mitochondrion a promising drug target in trypanosomatids?

Critical analysis of Chagas disease treatment in different countries

Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission

Population movements, borders, and Chagas disease

Prognosis of chronic Chagas heart disease and other pending clinical challenges

A history of over 40 years of potentially pathogenic free-living amoeba studies in Brazil - a systematic review

The translational challenge in Chagas disease drug development

Parasitological, serological and molecular diagnosis of acute and chronic Chagas disease: from field to laboratory

Chagas disease in the context of the 2030 agenda: global warming and vectors

The multidimensional comprehension of Chagas disease. Contributions, approaches, challenges and opportunities from and beyond the Information, Education and Communication field

Why do we still have not a vaccine against Chagas disease?

Emerging and reemerging forms of Trypanosoma cruzi transmission

The history of Chagas disease: reflections on science in action

Different profiles and epidemiological scenarios: past, present and future

ERRATUM

Molecular mechanisms of action of trypanocidal and leishmanicidal drugs with focus on novel chemotherapeutic strategies: creation of a Brazilian multicentre working group

Where the DNA hides... In praise of José Rodrigues Coura

Significance of a neglected tropical disease: lessons from a paradigmatic case of ‘success in translation’

Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease

Predictors of Trypanosoma cruzi PCR positivity in patients with chronic Chagas disease

Histone deacetylase (HDAC) inhibitors- based drugs are effective to control Mycobacterium tuberculosis infection and promote the sensibility for rifampicin in MDR strain

Unique synapomorphies and high diversity in South American Raji-related Epstein-Barr virus genomes

Heavy metal resistance in the Yanomami and Tunapuco microbiome

Zoonotic Giardia duodenalis assemblage A in northern sloth from Brazilian Amazon

Antileishmanial effects of γCdcPLI, a phospholipase A2 inhibitor from Crotalus durissus collilineatus snake serum, on Leishmania (Leishmania) amazonensis

Long COVID-19 syndrome associated with Omicron XBB.1.5 infection: a case report

Relevance of national, regional and global virome projects on pandemics prediction, prevention, and control: a social network analysis of GVP-citing articles

Benznidazole treatment decreases IL-6 levels in Trypanosoma cruzi-infected human adipocytes differentiated from adipose tissue-derived stem cells

Unveiling the genome of a high-risk pandrug-resistant Klebsiella pneumoniae emerging in the Brazilian Amazon Region, 2022

Microbiome and virome on indoor surfaces of an Antarctic research ship

First report of putative Leishmania RNA virus 2 (LRV2) in Leishmania infantum strains from canine and human visceral leishmaniasis cases in the southeast of Brazil

Inscrever-se em IOC